die größte Wachstumsdynamik auf. Deutschland ist erst Mitte der 1990er Jahre mit dem BioRegio-Wettbewerb nennenswert in … Biotechnologie wird Deutschland vergleichend mit Großbritannien, Indien und Israel untersucht. Es werden die Spezifika der jeweiligen …Die Biotechnologie ist eine wissensintensive Querschnittstechnologie, der große Wachstumspotenziale zuerkannt werden …

cluster policies in Japan, Germany, and France as well as six prominent biotechnology clusters in these countries. Information …

The link between entrepreneur's network centrality and innovation performance has been broadly studied in knowledge …-intensive industries such as biotechnology. However, little research has been focused on the social mechanisms that allow innovators to … norms that are considered legitimated to carry out innovation in the biotech field. …

specialized commercialization capabilities. According to the predominant framework, if the innovation is protected by a strong … appropriabilty regime the optimal strategy is to license the innovation to an incumbent product firm. This paper argues by contrast … commercialize alone or to pursue a hybrid arrangement (called co-promotion) whereby it licenses the innovation but retains the …

-food companies' competitiveness, helping them to integrate biotechnology and offer innovative products. The method used to support …The competitiveness of the agro-industrial sector depends not only on its specific performance but also on the … character and degree of the innovation performance, vital to added value development and differentiation in the biobased value …

ways while making traditional attitudes outdated. Innovation, the process of bringing new products and services to market …, is one of the most important issue today. Innovation is responsible for raising the quality and lowering the prices of … products and services that have dramatically improved consumers. lives.Medical biotechnology and healthcare industry can be …

of placed-based policies designed to spur innovation clusters. We estimate that the adoption of subsidies for biotech …